The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 46, Issue 3, 2005, Pages 477-479

  Watkins, Hugh ^a   McKenna, William J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETER ABLATION; CLINICAL EXAMINATION; CLINICAL FEATURE; ECHOCARDIOGRAPHY; EDITORIAL; HEART LEFT VENTRICLE PERFORMANCE; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LITERATURE; MUSCLE RESECTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HEART SEPTUM; HUMANS; MALE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 22844438206     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.05.013     Document Type: Editorial

References (13)

1. J.G. Seidman, C. Seidman The genetic basis for cardiomyopathy from mutation identification to mechanistic paradigms (review) Cell 104 2001 557 567
2. H. Watkins, W.J. McKenna, L. Thierfelder Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy N Engl J Med 332 1995 1058 1064
3. H. Niimura, L.L. Bachinski, S. Sangwatanaroj Human cardiac myosin binding protein C mutations cause late-onset familial cardiac hypertrophy N Engl J Med 338 1998 1248 1257
4. J. Mogensen, T. Kubo, M. Duque Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations J Clin Invest 111 2003 209 216
5. B.J. Maron, R.A. Nishimura, W.J. McKenna Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY) Circulation 99 1999 2927 2933
6. B.J. Maron, W.J. McKenna, G.K. Danielson American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713
7. R.B. McCully, R.A. Nishimura, A.J. Tajik, H.V. Schaff, G.K. Danielson Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy Circulation 94 1996 467 471
8. C. Knight, A.S. Kurbaan, H. Seggewiss Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy outcome in the first series of patients Circulation 95 1997 2075 2081
9. H. Seggewiss, U. Gleichmann, L. Faber Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy acute results and 3-month follow-up in 25 patients J Am Coll Cardiol 31 1998 252 258
10. F.H. Gietzen, C.J. Leuner, L. Obergassel Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions Circulation 106 2002 454 459
11. O.M. Hess, U. Sigwart New treatment strategies for hypertrophic obstructive cardiomyopathy: alcohol ablation of the septum: the new gold standard? J Am Coll Cardiol 44 2004 2054 2055
12. M.S. Maron, I. Olivotto, S. Betocchi Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303
13. S.R. Ommen, B.J. Maron, I. Olivotto Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 46 2005 470 476